Delivery Order SPE2DB20D3101-SPE2DB23FRFQ4

Award Date 3/20/23
Potential Completion Date 3/21/23
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of 4,567,238,309 units of Doxycycline Hyclate 100 mg tablets, valued at $2,282.83. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,630.73 firm fixed-price delivery order is for the provision of 4,559,305,900 units of Doxycycline Hyclate 100 mg tablets, with a completion date of December 8, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $2,381.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,792,342 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication, with a completion date of June 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,842,809 units of Doxycycline Hyclate 100 mg tablets, with a ceiling value of $1,093.88. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award, valued at $2,446.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,718,880 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,801.49 contract is for the delivery of 4,564,881 units of 100 mg doxycycline hyclate tablets. The order is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of 4,565,745,927 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product used to treat various bacterial infections. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,510.03 and runs through September 11, 2024. This award is a delivery order under a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,324.65 and is a delivery order with a firm fixed price pricing type. The contract is for the supply of 4,567,254,166 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product used in medical treatment. The contract has an ultimate completion date of February 13, 2025. This...
This federal contract award, valued at $1,063.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,558 tablets of Doxycycline Hyclate 100 mg, a common antibiotic medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, SPE2DX, which has a ceiling value of $999,999,999.00 and provides comprehensive global...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Doxycycline Hyclate 100 mg tablets. The award, valued at $1,691.26, was made by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRFQ4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,725.41 firm-fixed-price delivery order contract is for the supply of 4,560,318 units of Doxycycline Hyclate 100mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical commodities.

Generated 2/27/25, 11:35 AM